Loading...
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population
BACKGROUND: Antivascular endothelial growth factor tyrosine kinase inhibitors have been used recently in the treatment of advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Off-label sorafenib is used in Turkey with special permission by the Ministry of Health for this...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4271783/ https://ncbi.nlm.nih.gov/pubmed/25548522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S70670 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|